Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention
Josephine Warren, Shane Nanayakkara, Nick Andrianopoulos, Angela Brennan, Diem Dinh, Matias Yudi, David Clark, Andrew E Ajani, Christopher M Reid, Laura Selkrig, James Shaw, Chin Hiew, Melanie Freeman, David Kaye, Bronwyn A Kingwell, Anthony M Dart, Stephen J Duffy
Journal of the American College of Cardiology | ELSEVIER SCIENCE INC | Published : 2019
The Melbourne Interventional Group has received unrestricted educational grant funding from Abbott Vascular, AstraZeneca, Medtronic, Merck Sharp & Dohme, Pfizer, Servier, and The Medicines Company. These companies do not have access to the data, and do not have the right to review manuscripts before publication. Dr Nanayakkara is supported by a Heart Foundation Health Professional Scholarship and a Baker Bright Sparks scholarship. Dr. Yudi is supported by a combined National Health and Medical Research Council and National Heart Foundation Postgraduate Scholarship. Prof. Reid's and Prof. Duffy's work is funded by National Health and Medical Research Council of Australia Grants. Dr. Kingwell has research grant contracts with CSL Ltd. that are unrelated to the current publication. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. George Bakris, MD, served as Guest Associate Editor for this paper. A full list of the Melbourne Interventional Group Investigators can be found in the Online Appendix.